Abiopharma

New Form 8-K - ETHZilla Corp Filed: 2025-08-25 AccNo: 0001213900-25-080111 Size: 304 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Cassava Sciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

SCYNEXIS to Participate in the H.C. Wainwright 27th Annual Global Conference September 8 – 10, 2025

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

Evolus - Evolus Announces Positive Data From Pivotal Trial forEvolysse™ Sculpt Injectable Hyaluronic Acid Gel Product at 2025 Cosmetic Bootcamp

Natera - Natera to Present Signatera™ Data at the IASLC World Conference on Lung Cancer

SOBRsafe to Present at the 2025 Gateway Conference on September 3rd

Incyte Announces the Appointment of Soni Basi as Executive Vice President and Chief Human Resources Officer

DarioHealth Announces 20-to-1 Reverse Stock Split

New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2025

Artelo Biosciences Announces New Data from an Initial Food Effect Investigation with ART26.12, a Novel Non-Opioid Treatment Candidate for Persistent Pain

New Form SC14D9C - scPharmaceuticals Inc. Filed: 2025-08-25 AccNo: 0001193125-25-186996 Size: 9 KB

New Form SC TO-C - MANNKIND CORP Filed: 2025-08-25 AccNo: 0001193125-25-186995 Size: 4 MB

New Form 8-K - scPharmaceuticals Inc. Filed: 2025-08-25 AccNo: 0001193125-25-186993 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - MANNKIND CORP Filed: 2025-08-25 AccNo: 0001193125-25-186994 Size: 4 MB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits